Central AsianResearch Index

PET/CT IN ASSESSING THE LYMPHOMA RESPONSE TO TREATMENT

Relevance: PET/CT has become an integral part of the diagnostic algorithm in lymphoma patients since lymphomas actively accumulate 18F-FDG. The high accuracy of PET/CT in patients with certain lymphoma types allows effective use of this method in clinical practice for diagnosis, staging, re-staging, evaluating the effectiveness of treatment, and determining further patient management tactics. The study aimed to evaluate the PET/CT capacity in assessing lymphoma treatment effectiveness. Methods: We conducted a retrospective analysis of PET/CT 18F-FDG results in 109 patients with a verified lymphoma diagnosis. The patients underwent PET/CT examinations at “Orhun Medical” PET/CT center based in the JSC “Kazakh Institute of Oncology and Radiology” (Almaty, Kazakhstan). Results: According to PET/CT results in assessing the lymphoma treatment effectiveness, the stabilization of the process was achieved in 38.5% of cases, progression – in 33.03%, a partial metabolic response – in 18.35%, and a complete response – in 10.09% of cases. Conclusion: PET/CT is the method of choice for evaluating the effectiveness of lymphoma treatment compared to other radiological techniques. PET/CT is based on determining metabolic treatment response, not only on size indicators. It plays an essential role in different stages of lymphoma treatment, providing new opportunities for personalized treatment.

Сведения

Опубликовано
2022 · Т. 63, № 1, С. 32-35
Язык
Английский
ISSN
1684-937X · 2521-6414
Издатель
Kazakh Institute of Oncology and Radiology
Аффилиации
Asfendiyarov Kazakh National Medical University
1. Asfendiyarov Kazakh National Medical University 2. JSC «Kazakh Institute of Oncology and Radiology»